BPC-157 may not be appropriate when: Imaging or specialist review has not yet been completed for a suspected structural injury There are acute red flag features (severe weakness, fever, rapid unexplained swelling, neurological changes, unexplained weight loss) The patient has active cancer or a history of certain cancers where angiogenic peptides require careful risk assessment The goal is rapid results without addressing underlying load, rehabilitation, or lifestyle drivers A peptide should not be used to delay evaluation that is clearly warranted
For GI symptom management, adding BPC-157 during dose escalation makes sense
In animal studies, BPC-157 accelerates tendon to bone healing and antagonizes the tissue damage induced by corticosteroids, indicating it could help restore local tissue integrity that is important for embryo implantation and uterine function
So the real questions are: What does BPC 157 do
You can learn more about this protocol on our BPC-157 page or during your consultation at Relive Health West Nashville